Clearmind Medicine Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Cash & Equivalents	11.42	3.92	6.57	5.43	0.13	3.71
Short-Term Investments	2.18	1.66	0.29	0.09	0.19	-
Cash & Short-Term Investments	13.59	5.59	6.86	5.51	0.32	3.71
Cash Growth	192.32%	-18.62%	24.47%	1609.58%	-91.32%	1400.73%
Other Receivables	0.55	0.32	0.18	0.24	0.1	0.13
Total Trade Receivables	0.55	0.32	0.18	0.24	0.1	0.13
Other Current Assets	0.18	0.04	0.04	0.04	0.01	0.13
Total Current Assets	14.32	5.95	7.09	5.79	0.43	3.97
Net Property, Plant & Equipment	0.09	0.02	0.05	0	0.05	0.02
Other Intangible Assets	0.09	0.1	0.11	0.12	0.13	0.16
Other Long-Term Assets	0.02	0.02	0.01	0.04	0.21	0.02
Total Assets	14.52	6.08	7.26	5.95	0.83	4.17
Accounts Payable	0.81	0.74	0.58	0.66	1.6	0.29
Short-Term Debt	-	1.76	-	-	-	-
Current Portion of Leases	0.04	0.02	0.04	-	0.04	-
Other Current Liabilities	2.14	2.37	3.52	4.31	0.29	-
Total Current Liabilities	2.99	4.89	4.13	4.97	1.93	0.29
Long-Term Leases	0.04	-	0.02	-	-	-
Total Long-Term Liabilities	0.04	-	0.02	-	-	-
Total Liabilities	3.03	4.89	4.15	4.97	1.93	0.29
Common Stock	42.66	26.4	24.17	17.13	6.71	6.38
Additional Paid-in Capital	2.63	2.69	2.98	2.64	2.36	1.08
Accumulated Other Comprehensive Income	-0.02	-0.02	-0.02	-0.02	-0.02	-
Retained Earnings	-33.78	-27.88	-24.02	-18.77	-10.15	-3.58
Shareholders' Equity	11.49	1.19	3.11	0.98	-1.11	3.88
Total Liabilities & Equity	14.52	6.08	7.26	5.95	0.83	4.17
Total Debt	0.09	1.78	0.05	0	0.04	0
Net Cash (Debt)	13.51	3.81	6.81	5.51	0.28	3.71
Net Cash Growth	192.74%	-44.10%	23.51%	1840.56%	-92.35%	1400.73%
Net Cash Per Share	121.36	299.51	-	-	-	-
Book Value	11.49	1.19	3.11	0.98	-1.11	3.88
Book Value Per Share	103.24	93.84	-	-	-	-
Tangible Book Value	11.4	1.1	3	0.86	-1.24	3.72
Tangible Book Value Per Share	102.41	86.17	-	-	-	-

SEC Filings: 10-K · 10-Q